Pfizer’s first-quarter revenues disappoint New drugs spurred along by research at Pfizer Inc. laboratories in Groton couldn't provide enough lift to make up for losses in the company's established portfolio as the firm announced disappointing first-quarter financial results Tuesday. The drug gi... [News Source]

Pharmaceutical Lawsuit Funding Pact Between Legal-Bay and Route72 Legal-Bay LLC, The Lawsuit Settlement Funding Company, and Route 72 have begun a strategic relationship for both companies to begin marketing to and funding plaintiffs of bad pharmaceutical drugs.Fairfield, NJ (PRWEB) November 16, 2012 Legal-Bay (http://lawsuitssettlementfunding.com) is an industry leader in lawsuit funding and is looking to begin larger funding amounts for “pharma” drug ... [News Source]

Pharmaceutical Lawsuit Funding Pact Between Legal-Bay and Route72 Legal-Bay LLC, The Lawsuit Settlement Funding Company, and Route 72 have begun a strategic relationship for both companies to begin marketing to and funding plaintiffs of bad pharmaceutical drugs. (PRWeb November 16, 2012) Read the full story at http://www.prweb.com/releases/bad-drug/legal-bay/prweb10140764.htm [News Source]

California Class Action Lawsuit About Prescription HRT Medications Premarin, Prempro , and Premphase Certified and … SAN DIEGO, Oct. 16, 2012 /PRNewswire-USNewswire/ -- The following is being issued by the law firms of Beasley Allen, P.C., Gary Holt & Associates, P.A., and Rushall & McGeever:Official notice to potential Class Members has begun in a class action lawsuit that claims that drug manufacturer Wyeth violated California laws by misrepresenting the benefits and/or failing to disclose the risks of the ... [News Source]

California Class Action Lawsuit About Prescription HRT Medications Premarin, Prempro , and Premphase Certified and … SAN DIEGO, Oct. 16, 2012 /PRNewswire-USNewswire/ -- The following is being issued by the law firms of Beasley Allen, P.C., Gary Holt & Associates, P.A., and Rushall & McGeever:Official notice to potential Class Members has begun in a class action lawsuit that claims that drug manufacturer Wyeth violated California laws by misrepresenting the benefits and/or failing to disclose the risks of the ... [News Source]

Hormone Replacement Responsible for Breast Cancer Utah jury awards $5.1 million to the plaintiff in a Hormone Replacement Therapy (HRT) case; finds Prempro makers failed to adequately warn women of risk [News Source]

Courts » Drug companies ordered to pay $5.1 million, but vow to appeal. A federal jury awarded $5.1 million in compensatory damages to a Utah woman Friday after finding hormone therapy drugs caused her breast cancer and drug makers failed to adequately warn of that risk on labels provided to doctors and patients. [News Source]